Skip to main content

Kouzelos Michael P's Form 4/A amendment

Amended

CBIZ, Inc.CBZ · filed Mar 14, 2022

Accession no.
0001127602-22-009101
Filed
Mar 14, 2022
Trade date
May 4-5, 2021
Filing delay
314 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
May 6, 2021

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.02M. It was filed 314 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kouzelos Michael PCIK 0001641312Officer (President, Employee Services)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
–Common StockMOption exerciseAcquired+24,728$10.35+$255,934.8297,703DirectInvalid date
May 4, 2021Common StockSSaleDisposed−24,728$34.19F2−$845,450.32259,456Direct
May 5, 2021Common StockMOption exerciseAcquired+5,097$10.35+$52,753.95264,553Direct
May 5, 2021Common StockSSaleDisposed−5,097$33.86F3−$172,584.42259,456Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
–Common StockMOption exerciseDisposed−24,728$0.00$05,097DirectInvalid date
May 5, 2021Common StockMOption exerciseDisposed−5,097$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Consists of Options granted 05/10/2016, vesting in 25% increments each year beginning 05/10/2017, and expiring on 05/10/2022.

F2

Weighted average sale price of price range between $33.83 and $34.29. Will provide upon request number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Weighted average sale price of price range between $33.63 and $34.12. Will provide upon request number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

On May 6, 2021, the Corporate Secretary filed a Form 4 that inadvertently failed to report the exercise and sale of 24,728 options on May 4, 2021.

Read the full filing on SEC EDGAR (opens in a new tab)